Evidence map›Paper›PMID 28990310›Full record

ArticlePigment cell & melanoma research2018

The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.

Irene Orlow, Yang Shi, Peter A Kanetsky, Nancy E Thomas, Li Luo, Sergio Corrales-Guerrero, Anne E Cust, Lidia Sacchetto, Roberto Zanetti, Stefano Rosso and 11 more

Abstract read
In one paragraph

Article in Pigment cell & melanoma research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Current Molecular Markers of Melanoma and Treatment Targets.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Irene OrlowDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-6234-6961
Yang ShiBiostatistics Shared Resource, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Peter A KanetskyDepartment of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
Nancy E ThomasDepartment of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Li LuoDepartment of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA.
Sergio Corrales-GuerreroDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Anne E CustCancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Camperdown, NSW, Australia.ORCID 0000-0002-5331-6370
Lidia SacchettoPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Roberto ZanettiPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Stefano RossoPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Bruce K ArmstrongSchool of Global and Population Health, The University of Western Australia, Perth, WA, Australia.
Terence DwyerNuffield Department of Obstetrics and Gynecology, The George Institute for Global Health, University of Oxford, Oxford, UK.
Alison VennMenzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Richard P GallagherCancer Control Research, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
Stephen B GruberUSC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Loraine D MarrettPrevention and Cancer Control, Cancer Care Ontario, Toronto, ON, Canada.
Hoda Anton-CulverDepartment of Epidemiology, School of Medicine, University of California at Irvine, Irvine, CA, USA.ORCID 0000-0002-9603-0110
Klaus BusamDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Colin B BeggDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marianne BerwickDepartment of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA.ORCID 0000-0001-5062-2180
GEM Study GroupDepartment of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
Melanoma RAS/BRAF Mutation:Heterogeneity-Risk-PrognosisR01CA112243 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMAS, NANCY E. · 2005 to 2014
$5.4M
Solar Exposure and Melanoma SurvivalR01CA112524 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 2005 to 2009
$2.5M
Validation of the use of whole-genome amplified DNA in a population-based studyR03CA173806 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ORLOW, IRENE · 2013 to 2014
$170k
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA118100NCI NIH HHS R01 CA112243NCI NIH HHS R01 CA112524NCI NIH HHS R03 CA173806NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Evidence on the relationship between the vitamin D pathway and outcomes in melanoma is growing, although it is not always clear. We investigated the impact of measured levels of sun exposure at diagnosis on associations of vitamin D receptor gene (VDR) polymorphisms and melanoma death in 3336 incident primary melanoma cases. Interactions between six SNPs and a common 3'-end haplotype were significant (p < .05). These SNPs, and a haplotype, had a statistically significant association with survival among subjects exposed to high UVB in multivariable regression models and exerted their effect in the opposite direction among those with low UVB. SNPs rs1544410/BsmI and rs731236/TaqI remained significant after adjustment for multiple testing. These results suggest that the association between VDR and melanoma-specific survival is modified by sun exposure around diagnosis, and require validation in an independent study. Whether the observed effects are dependent or independent of vitamin D activation remains to be determined.

Indexed as

Genetic Predisposition to DiseaseFemaleHaplotypesHumansMaleMelanomaPolymorphism, Single NucleotideReceptors, CalcitriolRisk FactorsSunlightSurvival AnalysisReceptors, CalcitriolVDR protein, humanexposurehaplotypeinteractionmelanomapolymorphismSNPsurvivalUVBvitamin D receptor

Identifiers

PMID28990310
PMCPMC5809306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.